Open Access

Erratum to: Opportunities and obstacles to the development of nanopharmaceuticals for human use

DARU Journal of Pharmaceutical Sciences201624:25

https://doi.org/10.1186/s40199-016-0164-7

Received: 1 November 2016

Accepted: 2 November 2016

Published: 10 November 2016

The original article was published in DARU Journal of Pharmaceutical Sciences 2016 24:23

Erratum

After publication of this article [1], the authors clarify that Nasser Nassiri Koopaei was affiliated to “Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran” at the time the research was carried out.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Pharmaceutics, School of Pharmacy, University of Florida
(2)
Department of Toxicology & Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences
(3)
Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences
(4)
Toxicology Interest Group, Universal Scientific Education and Research Network, Tehran University of Medical Sciences

Reference

  1. Koopaei NN, Abdollahi M. Opportunities and obstacles to the development of nanopharmaceuticals for human use. DARU. 2016;24:23. doi:10.1186/s40199-016-0163-8.View ArticleGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement